Logo image of JTC.CA

JEMTEC INC (JTC.CA) Stock Fundamental Analysis

TSX-V:JTC - TSX Venture Exchange - CA4759012038 - Common Stock - Currency: CAD

0.9  +0.04 (+4.65%)

Fundamental Rating

5

JTC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 14 industry peers in the Electronic Equipment, Instruments & Components industry. JTC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. JTC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year JTC was profitable.
JTC had a positive operating cash flow in the past year.
Of the past 5 years JTC 4 years were profitable.
JTC had a positive operating cash flow in each of the past 5 years.
JTC.CA Yearly Net Income VS EBIT VS OCF VS FCFJTC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200K -200K 400K 600K

1.2 Ratios

JTC has a Return On Assets of 3.65%. This is in the better half of the industry: JTC outperforms 71.43% of its industry peers.
The Return On Equity of JTC (4.46%) is better than 71.43% of its industry peers.
The Return On Invested Capital of JTC (5.09%) is better than 71.43% of its industry peers.
Industry RankSector Rank
ROA 3.65%
ROE 4.46%
ROIC 5.09%
ROA(3y)5.67%
ROA(5y)12.16%
ROE(3y)5.77%
ROE(5y)13.9%
ROIC(3y)N/A
ROIC(5y)N/A
JTC.CA Yearly ROA, ROE, ROICJTC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

JTC has a better Profit Margin (5.87%) than 78.57% of its industry peers.
JTC's Profit Margin has declined in the last couple of years.
JTC's Operating Margin of 9.68% is amongst the best of the industry. JTC outperforms 85.71% of its industry peers.
In the last couple of years the Operating Margin of JTC has declined.
Looking at the Gross Margin, with a value of 51.52%, JTC is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Gross Margin of JTC has declined.
Industry RankSector Rank
OM 9.68%
PM (TTM) 5.87%
GM 51.52%
OM growth 3Y-31.62%
OM growth 5Y-19.16%
PM growth 3Y-38.2%
PM growth 5Y-24.49%
GM growth 3Y-11.58%
GM growth 5Y-8.32%
JTC.CA Yearly Profit, Operating, Gross MarginsJTC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

8

2. Health

2.1 Basic Checks

JTC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, JTC has about the same amount of shares outstanding.
JTC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for JTC has been reduced compared to a year ago.
JTC.CA Yearly Shares OutstandingJTC.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
JTC.CA Yearly Total Debt VS Total AssetsJTC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

JTC has an Altman-Z score of 5.07. This indicates that JTC is financially healthy and has little risk of bankruptcy at the moment.
JTC's Altman-Z score of 5.07 is fine compared to the rest of the industry. JTC outperforms 64.29% of its industry peers.
JTC has a debt to FCF ratio of 0.80. This is a very positive value and a sign of high solvency as it would only need 0.80 years to pay back of all of its debts.
JTC's Debt to FCF ratio of 0.80 is amongst the best of the industry. JTC outperforms 92.86% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that JTC is not too dependend on debt financing.
The Debt to Equity ratio of JTC (0.08) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.8
Altman-Z 5.07
ROIC/WACC0.67
WACC7.63%
JTC.CA Yearly LT Debt VS Equity VS FCFJTC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M 1.5M 2M

2.3 Liquidity

JTC has a Current Ratio of 8.87. This indicates that JTC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of JTC (8.87) is better than 92.86% of its industry peers.
JTC has a Quick Ratio of 8.87. This indicates that JTC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 8.87, JTC belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.87
Quick Ratio 8.87
JTC.CA Yearly Current Assets VS Current LiabilitesJTC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2

3. Growth

3.1 Past

JTC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 160.73%, which is quite impressive.
The earnings per share for JTC have been decreasing by -28.61% on average. This is quite bad
The Revenue has grown by 23.46% in the past year. This is a very strong growth!
JTC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.58% yearly.
EPS 1Y (TTM)160.73%
EPS 3Y-45.34%
EPS 5Y-28.61%
EPS Q2Q%225%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y-12.02%
Revenue growth 5Y-5.58%
Sales Q2Q%22.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JTC.CA Yearly Revenue VS EstimatesJTC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

3

4. Valuation

4.1 Price/Earnings Ratio

JTC is valuated rather expensively with a Price/Earnings ratio of 22.50.
Based on the Price/Earnings ratio, JTC is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
JTC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 23.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.5
Fwd PE N/A
JTC.CA Price Earnings VS Forward Price EarningsJTC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

92.86% of the companies in the same industry are more expensive than JTC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.53
EV/EBITDA -5.31
JTC.CA Per share dataJTC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JTC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JEMTEC INC

TSX-V:JTC (4/30/2025, 7:00:00 PM)

0.9

+0.04 (+4.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-25 2025-03-25
Earnings (Next)06-25 2025-06-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners50.18%
Ins Owner ChangeN/A
Market Cap2.51M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.5
Fwd PE N/A
P/S 1.37
P/FCF 7.53
P/OCF 7.51
P/B 1.04
P/tB 1.04
EV/EBITDA -5.31
EPS(TTM)0.04
EY4.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY13.28%
OCF(TTM)0.12
OCFY13.32%
SpS0.66
BVpS0.87
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.65%
ROE 4.46%
ROCE 6.69%
ROIC 5.09%
ROICexc 61.48%
ROICexgc 61.48%
OM 9.68%
PM (TTM) 5.87%
GM 51.52%
FCFM 18.16%
ROA(3y)5.67%
ROA(5y)12.16%
ROE(3y)5.77%
ROE(5y)13.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-45.29%
ROICexcg growth 5YN/A
ROICexc growth 3Y-45.29%
ROICexc growth 5YN/A
OM growth 3Y-31.62%
OM growth 5Y-19.16%
PM growth 3Y-38.2%
PM growth 5Y-24.49%
GM growth 3Y-11.58%
GM growth 5Y-8.32%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.8
Debt/EBITDA 0.65
Cap/Depr 0.86%
Cap/Sales 0.05%
Interest Coverage 6.66
Cash Conversion 118.46%
Profit Quality 309.37%
Current Ratio 8.87
Quick Ratio 8.87
Altman-Z 5.07
F-Score5
WACC7.63%
ROIC/WACC0.67
Cap/Depr(3y)32.01%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)160.73%
EPS 3Y-45.34%
EPS 5Y-28.61%
EPS Q2Q%225%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.46%
Revenue growth 3Y-12.02%
Revenue growth 5Y-5.58%
Sales Q2Q%22.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y202.24%
EBIT growth 3Y-39.84%
EBIT growth 5Y-23.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.1%
FCF growth 3Y13.29%
FCF growth 5Y-7.35%
OCF growth 1Y-15.51%
OCF growth 3Y13.14%
OCF growth 5Y-7.35%